Airway Innovations

What Airway Innovations does

Airway Innovations, Inc. is a privately held medical device company headquartered in Grand Rapids, Michigan, founded in 2016. The company develops the AERIS Airway, a first-of-its-kind single-use device that combines oxygen delivery and end-tidal CO2 (ETCO2) capnography monitoring into a traditional oropharyngeal (OPA) or nasopharyngeal (NPA) airway. The product is targeted at anesthesia providers — anesthesiologists, Certified Registered Nurse Anesthetists (CRNAs), and other clinicians administering I.V. sedation, Total Intravenous Anesthesia (TIVA), and post-deep extubation monitoring — and is positioned to help facilities comply with American Society of Anesthesiologists (ASA) guidelines for safe sedation.

The AERIS Airway replaces the conventional pairing of an OPA/NPA with separate nasal cannulas and a face mask, consolidating airway patency maintenance, supplemental oxygen delivery, and continuous capnography into one device. The company holds registered trademarks for the AERIS and AERIS Airway brands. Revenue is generated through direct hardware sales to healthcare facilities and anesthesia providers, with the company offering free product samples via its website as the primary demand-generation mechanism; pricing is not publicly disclosed. The stated U.S. total addressable market is 142 million+ OPAs and NPAs used annually, and the company operates exclusively in the United States. Leadership includes CEO Daniel Karadsheh and Founder/EVP Eric VanMiddendorp; disclosed funding is approximately $95,000 across three small rounds in 2020-2021.

Name

Airway Innovations

Legal name

Airway Innovations, Inc.

Website

https://airwayinnovations.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Airway Innovations is a Grand Rapids, Michigan medical device company that makes the AERIS Airway, a single-use device integrating oxygen delivery and end-tidal CO2 monitoring for anesthesia providers performing I.V. sedation, TIVA, and post-extubation care. It sells directly to clinicians and healthcare facilities.

Ownership category

akta.pro rank

Product category

Airway Management Medical Devices

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Airway Management Devices (ET Tubes, LMAs, Tracheostomy, Suction) (HLAHAGAF)

akta.pro secondary industries

Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters) (HLAHAGAG), Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate) (HLAHAGAI)

Keywords

• Airway management devices
• Oxygen delivery systems
• Capnography monitoring equipment
• Anesthesia care devices
• Medical device manufacturing

Headquarters

HQ city

Grand Rapids

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Medical Device Sales: Revenue generated from the sale of AERIS Airway devices to healthcare facilities and anesthesia providers. The company offers free samples to facilitate product evaluation and adoption.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Airway Innovations designs, manufactures, and sells the AERIS Airway™, a single-use medical device that combines supplemental oxygen delivery with end-tidal CO2 (capnography) monitoring for sedated and anesthetized patients. The device is positioned as a first-of-its-kind integrated solution for anesthesia and sedation providers, replacing the need for separate nasal cannula and sidestream capnography sampling lines.

Product overview

Airway Innovations offers a single unified product—the AERIS Airway™. This first-of-its-kind device transforms traditional oropharyngeal and nasopharyngeal airways into advanced oxygen delivery and CO2 monitoring systems for anesthesia and sedation applications. The product is designed for I.V. sedation, Total Intravenous Anesthesia (TIVA), and post-deep extubation scenarios, enabling anesthesia providers to meet ASA guidelines for safe and effective sedation. The company also provides related resources including FAQs and sample requests, but does not offer a modular platform or add-on product structure.

Differentiator

Problem solved

Functional benefit

Brands

• AERIS™: A first-of-its-kind oxygen delivery and end-tidal CO2 monitoring system designed for I.V. sedation, TIVA, and post deep extubation. Modernizes traditional Guedel oropharyngeal airways (OPA) and nasopharyngeal airways (NPA).
• AERIS Airway™

Products and services

• AERIS Airway A single-use medical device that combines supplemental oxygen delivery with end-tidal CO2 (capnography) sampling in a single nasal airway interface for sedated or anesthetized patients. Sold to anesthesia and sedation providers in hospitals, ambulatory surgery centers, and procedural suites.

Named customers4 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Ambu: Ambu is a major manufacturer of single-use airway management devices (OPAs, NPAs, laryngeal masks) and anesthesia/respiratory consumables. It is comparable because it sells the same core OPA/NPA products that AERIS modernizes, but across a much broader anesthesia and respiratory portfolio.
• Teleflex: Teleflex (including its Iso-Gard and Rusch lines) sells a leading portfolio of OPA/NPA airways, endotracheal tubes, and anesthesia consumables. It is comparable as an incumbent airway-device manufacturer that could integrate an O2/ETCO2 feature into its existing products.
• Smiths Medical (ICU Medical): Smiths Medical / ICU Medical offers Portex-brand OPA/NPA airways, tracheostomy tubes, and anesthesia delivery products. It is comparable as an incumbent airway-device vendor with the engineering depth to add integrated monitoring features.
• Medtronic: Medtronic's Respiratory Interventions business sells ETCO2 sampling lines, capnography monitors, and airway devices used in sedation and critical care. It is comparable because it dominates the capnography/ETCO2 monitoring side that AERIS integrates, and could bundle an OPA-style integrated product.
• Medline Industries: Medline manufactures and distributes a broad portfolio of OPA/NPA airways, anesthesia supplies, and respiratory consumables to hospitals and surgery centers. It is comparable as a major medical-supply incumbent in the same channel AERIS sells into.

Direct peers

• Intersurgical: Intersurgical manufactures a wide range of single-use airway management products (OPAs, NPAs, breathing circuits, Guedel airways) for anesthesia and critical care. It is a direct peer as an airway-management specialist competing in the same OPA/NPA category AERIS targets.
• Vyaire Medical: Vyaire Medical specializes in respiratory care and anesthesia consumables, including ventilation circuits, airways, and capnography accessories. It is a direct peer in the integrated respiratory/airway management space.
• SunMed: SunMed manufactures anesthesia and respiratory care consumables, including OPA/NPA airways, ETCO2 cannulas, and capnography accessories. It is a direct peer as a focused airway-management product company.
• Mercury Medical: Mercury Medical is a U.S.-based manufacturer of anesthesia and respiratory devices, including airway management products and ETCO2 sampling lines. It is comparable as a focused mid-market airway and respiratory device company.

Emerging players

• Masimo: Masimo is a leader in capnography and patient monitoring technology (e.g., EMMA capnograph, ISA CO2 analyzer) used in sedation and procedural settings. It is comparable as a focused ETCO2 monitoring company whose technology could be bundled with or compete against AERIS's integrated CO2 feature.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks8 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/airwayinnovations

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Airway Innovations